Several publications have demonstrated that CTLA‐4 and PD‐1 inhibitors as well as other immune checkpoint blockade therapies result in an increase in IFNγ production,3, 4, 5 which in turn lead to the elimination of cancer cells. Here, IFNG is linked to cancer.